دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Maintaining the HIV response in a world shaped by COVID-19
doi : 10.1016/S0140-6736(20)32526-5
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1703
FAST: new look at the febuxostat safety profile
Thomas Bardin, Pascal Richette
doi : 10.1016/S0140-6736(20)32343-6
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1704-1705
First-line treatment for type 2 diabetes: is it too early to abandon metformin?
Francesco Zaccardi, Kamlesh Khunti, Nikolaus Marx, Melanie J Davies
doi : 10.1016/S0140-6736(20)32523-X
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1705-1707
Emergency use authorisation for COVID-19 vaccines: lessons from Ebola
Maxwell J Smith, Samuel Ujewe, Rachel Katz, Ross E G Upshur
doi : 10.1016/S0140-6736(20)32337-0
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1707-1709
Leveraging the COVID-19 response to end preventable child deaths from pneumonia
Henrietta H Fore, Tedros Adhanom Ghebreyesus, Kevin Watkins, Leith Greenslade, ... Alma Golden
doi : 10.1016/S0140-6736(20)32348-5
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1709-1711
Osteoarthritis in 2020 and beyond: a Lancet Commission
David J Hunter, Lyn March, Mabel Chew
doi : 10.1016/S0140-6736(20)32230-3
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1711-1712
Offline: Europe and COVID-19—struggling with tragedy
Richard Horton
doi : 10.1016/S0140-6736(20)32530-7
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1713
Funding crisis threatens Palestinian refugee agency
Sharmila Devi
doi : 10.1016/S0140-6736(20)32527-7
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1714
New international group on antimicrobial resistance
John Zarocostas
doi : 10.1016/S0140-6736(20)32528-9
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1715
Afghanistan braced for second wave of COVID-19
Sophie Cousins
doi : 10.1016/S0140-6736(20)32529-0
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1716-1717
Applying for residency in the time of COVID-19
Tema Fodje, Esther Choo
doi : 10.1016/S0140-6736(20)32476-4
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1718
Steven Laureys: a clinical focus on consciousness research
Richard Lane
doi : 10.1016/S0140-6736(20)32477-6
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1719
A tribute to some of the doctors who died from COVID-19
Andrew Green
doi : 10.1016/S0140-6736(20)32478-8
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1720-1729
Psychoanalysis in combatting mass non-adherence to medical advice
Austin Ratner, Nisarg Gandhi
doi : 10.1016/S0140-6736(20)32172-3
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1730
Syndemic responses to COVID-19 should include an ecological dimension
Chris Kenyon
doi : 10.1016/S0140-6736(20)32219-4
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1730-1731
The COVID-19 syndemic is not global: context matters
Emily Mendenhall
doi : 10.1016/S0140-6736(20)32218-2
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1731
Maternal, neonatal, and child health is essential for meeting SDG 3.4
Neena Modi, Mark Hanson
doi : 10.1016/S0140-6736(20)32222-4
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1731-1732
Who should be prioritised for COVID-19 vaccines?
Zaki Hassan-Smith, Wasim Hanif, Kamlesh Khunti
doi : 10.1016/S0140-6736(20)32224-8
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1732-1733
The Nobel Prize for discovery of HCV is a call to end hepatitis
John W Ward
doi : 10.1016/S0140-6736(20)32282-0
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1733
SARS-CoV-2 risk misclassification explains poor COVID-19 management
Juan Mart?nez Hern?ndez
doi : 10.1016/S0140-6736(20)32169-3
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1733-1734
Harmful marketing to children
Darren Powell
doi : 10.1016/S0140-6736(20)32403-X
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1734-1735
Harmful marketing to children – Authors' reply
Anthony Costello, Sarah L Dalglish, Anshu Banerjee, Jeremy Shiffman, ... Helen Clark
doi : 10.1016/S0140-6736(20)32471-5
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1735
Ruxolitinib cream for the treatment of vitiligo
Shelley K Uppal, Donovan G Kearns, Vipawee S Chat, Jashin J Wu
doi : 10.1016/S0140-6736(20)32469-7
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1735-1736
Ruxolitinib cream for the treatment of vitiligo – Authors' reply
David Rosmarin, Kathleen Butler, Fiona Kuo, John E Harris
doi : 10.1016/S0140-6736(20)32470-3
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1736
Department of Error
doi : 10.1016/S0140-6736(20)32479-X
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1736
Department of Error
doi : 10.1016/S0140-6736(20)32480-6
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1736
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial
Johanne Silvain, Benoit Lattuca, Farzin Beygui, Grégoire Rangé, ... Martin PORZER
doi : 10.1016/S0140-6736(20)32236-4
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1737-1744
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Isla S Mackenzie, Ian Ford, George Nuki, Jesper Hallas, ... T. Waller
doi : 10.1016/S0140-6736(20)32234-0
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1745-1757
First human facial retransplantation: 30-month follow-up
Laurent Lantieri, Bernard Cholley, Cedric Lemogne, Romain Guillemain, ... Alexandre G Lellouch
doi : 10.1016/S0140-6736(20)32438-7
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1758-1765
A disease disregards anatomical planes: actinomycosis and an intrauterine device
Lucy Gilbert, Kyle Miller, Diogo Medeiros, Maria Tsatoumas, ... Princy N Kumar
doi : 10.1016/S0140-6736(20)32336-9
Volume 396, Issue 10264, 28 November–4 December 2020, Page 1766
Direct oral anticoagulants: evidence and unresolved issues
Noel Chan, Magdalena Sobieraj-Teague, John W Eikelboom
doi : 10.1016/S0140-6736(20)32439-9
Volume 396, Issue 10264, 28 November–4 December 2020, Pages 1767-1776
